Evaluation of P53 immunostaining in patients with cutaneous melanoma

Author:

Meevassana Jiraroch1,Mittrakulkij Chanya1,Toworrakul Ponteera1,Saensuk Wantamol1,Kamolratanakul Supitcha2,Siritientong Tippawan1,Ruangritchankul Komkrit3,Kitkumthorn Nakarin4

Affiliation:

1. Center of Excellence in Burn and Wound Care, Chulalongkorn University, Bangkok 10330, Thailand

2. Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand

3. Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand

4. Department of Oral Biology, Faculty of Dentistry, Mahidol University, Bangkok 10400, Thailand

Publisher

Spandidos Publications

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Reference24 articles.

1. Histologic criteria for diagnosing primary cutaneous malignant melanoma;Smoller;Mod Pathol,2006

2. From melanocyte to metastatic malignant melanoma;Bandarchi;Dermatol Res Pract,2010

3. Melanoma: Molecular pathogenesis and therapeutic management;Liu;Mol Cell Pharmaco,2014

4. P53 in skin cancer: From a master player to a privileged target for prevention and therapy;Loureiro;Biochim Biophys Acta Rev Cancer,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3